Sowery RD - Search Results

1

Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.

Sowery RD, Hadaschik BA, So AI, Zoubeidi A, Fazli L, Hurtado-Coll A, Gleave ME. Sowery RD, et al. BJU Int. 2008 Aug;102(3):389-97. doi: 10.1111/j.1464-410X.2008.07618.x. Epub 2008 Mar 11. BJU Int. 2008. PMID: 18336596 Clinical Trial.

2

Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin.

Muramaki M, So A, Hayashi N, Sowery R, Miyake H, Fujisawa M, Gleave ME. Muramaki M, et al. BJU Int. 2009 Feb;103(3):384-90. doi: 10.1111/j.1464-410X.2008.08098.x. Epub 2008 Oct 24. BJU Int. 2009. PMID: 19007378

3

Novel targets and approaches in advanced prostate cancer.

Hadaschik BA, Sowery RD, Gleave ME. Hadaschik BA, et al. Among authors: sowery rd. Curr Opin Urol. 2007 May;17(3):182-7. doi: 10.1097/MOU.0b013e3280dd8a4f. Curr Opin Urol. 2007. PMID: 17414516 Review.

4

Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.

Hadaschik BA, Ettinger S, Sowery RD, Zoubeidi A, Andersen RJ, Roberge M, Gleave ME. Hadaschik BA, et al. Among authors: sowery rd. Int J Cancer. 2008 May 15;122(10):2368-76. doi: 10.1002/ijc.23406. Int J Cancer. 2008. PMID: 18240145 Clinical Trial.

5

Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.

Hadaschik BA, ter Borg MG, Jackson J, Sowery RD, So AI, Burt HM, Gleave ME. Hadaschik BA, et al. Among authors: sowery rd. BJU Int. 2008 Jun;101(11):1347-55. doi: 10.1111/j.1464-410X.2008.07571.x. Epub 2008 Apr 2. BJU Int. 2008. PMID: 18384637

6

[Stress proteins in prostate cancer. Challenge and promise].

Hadaschik BA, Melchior SW, Sowery RD, So AI, Gleave ME. Hadaschik BA, et al. Among authors: sowery rd. Urologe A. 2007 May;46(5):516-20. doi: 10.1007/s00120-007-1323-8. Urologe A. 2007. PMID: 17372715 Review. German.

7

Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.

Zoubeidi A, Zardan A, Beraldi E, Fazli L, Sowery R, Rennie P, Nelson C, Gleave M. Zoubeidi A, et al. Cancer Res. 2007 Nov 1;67(21):10455-65. doi: 10.1158/0008-5472.CAN-07-2057. Cancer Res. 2007. PMID: 17974989 Free article.

8

The role of stress proteins in prostate cancer.

So A, Hadaschik B, Sowery R, Gleave M. So A, et al. Curr Genomics. 2007 Jun;8(4):252-61. doi: 10.2174/138920207781386951. Curr Genomics. 2007. PMID: 18645594 Free PMC article.

9

The best local therapy for unfavorable risk prostate cancer: the role of surgery.

Studd RC, Sowery RD, Gleave ME. Studd RC, et al. Among authors: sowery rd. Minerva Urol Nefrol. 2006 Sep;58(3):99-118. Minerva Urol Nefrol. 2006. PMID: 17124481 Review.

10

Therapeutic options in advanced prostate cancer: present and future.

Sowery RD, So AI, Gleave ME. Sowery RD, et al. Curr Urol Rep. 2007 Jan;8(1):53-9. doi: 10.1007/s11934-007-0021-9. Curr Urol Rep. 2007. PMID: 17239317 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters